Related Experiment Video
Updated: Jun 10, 2026
Correlative Light- and Electron Microscopy Using Quantum Dot Nanoparticles
Published on: August 7, 2016
A Quick and Parallel Analytical Method Based on Quantum Dots Labeling for ToRCH-Related Antibodies.
1Department of Bio-Nano Science and Engineering, Key Laboratory for Thin Film and Microfabrication Technology of Ministry of Education, National Key Laboratory of Micro/Nano Fabrication Technology,Research Institute of Micro/Nano Science and Technology, Shanghai Jiao Tong University, 200240, Shanghai, People's Republic of China. dxcui@sjtu.edu.cn.
Quantum dots offer a rapid and stable method for detecting ToRCH-related antibodies. This new quantum dot (QD)-based microarray shows comparable accuracy to ELISA, with significant advantages in speed and cost for diagnosing infections like Toxoplasma gondii and Rubella virus.
Area of Science:
- Nanomaterials Science
- Biotechnology
- Immunodiagnostics
Background:
- Quantum dots (QDs) are nanomaterials with unique optical properties, including high quantum yield and photostability, making them suitable for biological labeling.
- Accurate and efficient detection of ToRCH infections (Toxoplasma gondii, Rubella virus, Cytomegalovirus, Herpes simplex virus) is crucial in obstetric care.
Purpose of the Study:
- To develop a quick, parallel analytical method using quantum dots for detecting ToRCH-related antibodies in clinical samples.
- To evaluate the performance of a quantum dot-based ToRCH microarray assay compared to the established enzyme-linked immunosorbent assay (ELISA).
Main Methods:
- Fabrication of microarrays containing five ToRCH-related antigens.
- Labeling of secondary antibodies with Cadmium Telluride (CdTe) quantum dots.
- Analysis of 100 clinical serum specimens from obstetric outpatients using the QD-based microarray.
- Comparison of results with traditional ELISA kits.
Main Results:
- The quantum dot-labeled ToRCH microarray demonstrated sensitivity and specificity comparable to ELISA.
- The QD-based assay exhibited significant advantages over ELISA in terms of detection time, cost, operational simplicity, and signal stability.
- Clinical validation confirmed the reliability of the QD-based ToRCH microarray.
Conclusions:
- Quantum dot-based microarrays provide a highly effective platform for the rapid and parallel detection of ToRCH-related antibodies.
- This method holds substantial potential for improving the diagnosis of ToRCH infections in clinical settings, offering a superior alternative to current methods like ELISA.
